Xirestomig
Chemical
FDA Substance Registry (openFDA)
Learn more about this substance:
Ask ChatGPT
Google
PubChem
Wikipedia
EWG Skin Deep
INCIDecoder
ECHA
Chemical Identification
| CAS Number | 2756879-35-1 |
|---|
Known Aliases (5)
Common Name
ATG-101
ATG101
Immunoglobulin G1 [301-alanine], bispecific, anti-(programmed death-ligand 1) (human monoclonal ATG-101 γ1-chain) fusion protein with peptide linker (GGGGS)3 fusion protein with immunoglobulin anti-(human tumor necrosis factor receptor TNFRSF9) (human single-chain variable fragment VH-(GGGGS)3-VL), disulfide with human monoclonal ATG-101 λ-chain, dimer
immunoglobulin G1-scFv_L2 dimer, anti-[Homo sapiens CD274 (programmed cell death 1 ligand 1, PDL1, PD-L1,B7 homolog 1, B7H1, B7-H1, PDCD1LG1) and anti-[Homo sapiens TNFRSF9 (TNF receptor superfamily member 9,4-1BB, T cell antigen ILA, CD137)], Homo sapiens monoclonal antibody, bispecific
xirestomig [INN]
Data Sources (1)
| Source | Source ID | Name in Source | Properties |
|---|---|---|---|
| FDA Substance Registry (openFDA) | Q2C2VG7V4N |
Xirestomig |
CAS: 2756879-35-1 INN: 12746 SMS_ID: 300000051888 FDA UNII: Q2C2VG7V4N NCI_THESAURUS: C190124 FDA ORPHAN DRUG: 899222 |
Record Info
| ID | 7YmBYJ5FSsXMqZSNx5sPGy |
|---|---|
| Created | April 10, 2026, 8:14 p.m. |
| Modified | April 11, 2026, 12:27 a.m. |
| Data Source | FDA Substance Registry (openFDA) |